Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYT1 antisense RNA 1 (SYT1-AS1)
- Target
- SYT1-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Non-protein-coding RNA
01
Overview
SYT1 antisense RNA 1 is a long non-coding antisense RNA transcribed from the genomic region antisense to the Synaptotagmin-1 (SYT1) gene[4]. Like other antisense RNAs, SYT1-AS1 likely plays a regulatory role by interacting with SYT1 mRNA, potentially influencing transcription, translation, mRNA stability, or chromatin structure, either in cis (locally) or trans (globally)[2]. The precise biological significance, disease relevance, and molecular mechanisms of SYT1-AS1 remain poorly characterized, as is common for many antisense long non-coding RNAs. There are currently no drugs or clinical applications targeting SYT1-AS1, and it is not employed as a biomarker. *Note*: If your intention was to refer to Synaptotagmin-1 (SYT1), which is a well-known calcium sensor and therapeutic target in neurology and synaptic transmission research, the information would differ significantly[1][3][5][7]. SYT1-AS1, however, refers specifically to the non-coding RNA, not the protein.
- Other names
- SYT1 antisense RNA 1SYT1-AS1AC027288.3
02
Biological functions
Regulation of gene expression (usually affects the SYT1 protein-coding gene by antisense interactions)Potential involvement in transcriptional interferenceModulation of chromatin organizationPossible alteration of mRNA stability
03
Disease associations
No documented direct disease link for SYT1-AS1 itself, but antisense RNAs and lncRNAs can be implicated in disease processes, often through regulation of associated protein-coding genes[2][4]
Beyond the preview
Go deeper on SYT1 antisense RNA 1 (SYT1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYT1 antisense RNA 1 (SYT1-AS1).